DCGO

DocGo Inc

Health Care · USD

DCGO

Price

$0.539

+11.54%

Cap

$57M

Earnings

0/3 beat

30d Trend

+12%

DCGO
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range2%
0.4912.45

Near 52-week lows — potential value or falling knife

Analyst consensus (5 analysts)+342% to target
0 Strong Buy3 Buy2 Hold0 Sell0 Strong Sell

Target range: $1$3 (consensus: $2.38)

Consensus: Buy

Earnings history

Q4 2025

MISS

-1.37 vs -0.24

Q3 2025

MISS

-0.11 vs -0.09

Q2 2025

MISS

-0.11 vs -0.03

VolatilityHigh

Key macro factors

·

Inflation (US Inflation to 3.3%) and 'Higher for Longer' Rates: DocGo, as a healthcare services provider, faces increased operating costs due to inflation (e.g., fuel for transportation, wages for staff, medical supplies). Higher interest rates may also increase borrowing costs for expansion or operational needs, impacting profitability.

·

Q1 2026 Earnings Season Kicks Off: DocGo's performance will be viewed in the context of broader healthcare sector earnings. Concerns regarding the wind-down of migrant-related revenue, a significant factor in recent quarters, mean overall sector health and comparable company performance will be key indicators for investors.

·

Strait of Hormuz Closure Sustains Oil Price Volatility: DocGo's Transportation Services segment, including ambulance and non-emergency medical transport, is directly vulnerable to fluctuations in oil prices. Sustained volatility or increases in fuel costs could significantly impact operational expenses and reduce profit margins.

DocGo Inc. is a provider of technology-enabled mobile health and medical transportation services in the United States and the United Kingdom.

Next earnings:2026-05-11

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

DocGo Inc (DCGO) — Brain47 AI Score 54/100 | Analysis